Featured
Last news
Jaguar Health Makes Submission to EMA Regarding EU Approval Pathway for Canalevia for General Diarrhea in Dogs Based on Data from Completed Study
Jaguar's requesting advice from EMA on EU approval pathway for general diarrhea of FDA conditionally approved Canalevia®A novel non-antibiotic approach to diarrhea treatment is important because there are no FDA-approved drugs to treat general diarrhea in dogs, the second most common reason for visits to veterinary emergency hospitals
NGCG Announces Development of Spiritual Glow Smartphone Application by Signature Apps
PHOENIX, AZ / ACCESS Newswire / December 2, 2025 / New Generation Consumer Group, Inc. (OTCID:NGCG) is pleased to announce that Signature Apps, the Company's technology and development subsidiary, has officially begun work on a dedicated smartphone application for Spiritual Glow, NGCG's recently announced acquisition in the wellness and spiritual lifestyle sector.
DDC's Two Month Reset Turned a Volatile Story Into a Ripe Opportunity
NEW YORK, NY / ACCESS Newswire / December 2, 2025 / Every cycle forces investors to rethink what a modern consumer company should look like. Some names respond with tighter cost controls, some with brand refreshes, and some with a full structural overhaul. DDC Enterprise Limited (NYSE American:DDC) sits in that last category. It isn't trying to polish its past. It is trying to rebuild the architecture underneath it. That kind of ambition creates discomfort, curiosity, and attention at the same time.
Stemtech Corporation Announces Entry into China in a Joint Venture with Lightway Ventures
NAPLES, FL / ACCESS Newswire / December 2, 2025 / Stemtech Corporation, the global leader and pioneer in stem cell nutrition, is proud to announce a key strategic agreement to open a joint venture to establish distribution of Stemtech Products in China with Lightway Ventures. Stemtech Asia (Hong Kong) is being established, subject to final funding and regulatory approvals, and will be under the corporate structure of Stemtech Corporation, a Nevada USA holding company (OTCQB: "STEK").
Dogwood Therapeutics Files New Synthetic Halneuron(R) Intellectual Property Protection Projected to Extend Exclusivity Period Up to 2045
- New Composition of Matter Intellectual Property ("IP") Filing Centered on First-in-Class, Fully Synthetically Manufactured Halneuron®-- New Synthetic Process to be Used for Phase 3 Development Provides Higher Manufacturing Yields and Reduces Costs Versus Naturally Harvested Halneuron® -
Ensysce Biosciences Announces Broader Patent Protection for Groundbreaking MPAR(R) Overdose Protection Technology
~ New U.S. Patent Extends Protection Through 2042 ~~ Patent Allowance Secures Highest Level of Intellectual Property Protection for MPAR® ~
Doctor Becomes First in Illinois to Perform Revolutionary, Minimally Invasive Bladder Control Procedure
DOWNERS GROVE, IL / ACCESS Newswire / December 2, 2025 / Dr. Sarah Martin, a women's urology specialist at Duly Health and Care's Chicagoland medical group, DuPage Medical Group, Ltd., this month became the first physician in Illinois to perform a cutting-edge, minimally invasive bladder control procedure using the Altaviva™ implant.
Avel eCare Welcomes Pat Gundersen as New Chief Revenue Officer
SIOUX FALLS, SD / ACCESS Newswire / December 2, 2025 / Avel eCare is pleased to announce the appointment of Pat Gundersen as its new Chief Revenue Officer, bringing more than twenty years of leadership experience in healthcare, healthcare technology, and go-to-market strategy.
Organto Foods Highlights Strong Growth Momentum and Strategic Evolution Following Successful Restructuring
Focused on advancing its strategy for sustainable, scalable expansion, the Company unveils its refreshed brand identity, outlines its integrated farm-to-shelf model and details its disciplined path for future growth.
CBD Life Sciences Inc. (CBDL) CEO Lisa Nelson Interviews With The Morning Show
"Inside the explosive rise of a wellness company outpacing a $200B+ global market"Watch the full Morning Show interview →
GEN Announces New Positive Phase 1 Trial Data of the Investigational Drug SUL-238 for Alzheimer's and Other Neurodegenerative Diseases
Phase 1 results show that SUL-238 is safe, well-tolerated, and demonstrates favorable pharmacokinetics with high CSF penetration in healthy elderly volunteers, supporting its advancement into further clinical development for Alzheimer's and other neurodegenerative diseases.
Son of Mexican crime lord 'El Chapo' pleads guilty in drug case
A son of the infamous Mexican drug lord Joaquin "El Chapo" Guzman pleaded guilty Monday in a Chicago court to drug trafficking charges in a deal that would see him cooperate with US prosecutors for a reduced sentence.
12 dead, dozens missing as landslide submerges boats in Peru port
At least 12 people, including three children, died Monday when a landslide sank two boats docked at a river port in central Peru, with dozens of others missing, officials said.
Rich art: French pastry chefs auction chocolate sculptures
Chocolate artworks by some of France's most famous pastry chefs sold at auction Monday for more than 100,000 euros in a charity event that had bidders smacking their lips.
Son of Mexican crime lord 'El Chapo' pleads guilty in drug case: US media
A son of the infamous Mexican drug lord Joaquin "El Chapo" Guzman pleaded guilty Monday in Chicago to a narcotics trafficking charge and continuing criminal enterprise, US media reported.
Iran sentences director Jafar Panahi to year in prison: lawyer
Iran has sentenced Palme d'Or-winning filmmaker Jafar Panahi in absentia to one year in prison and a travel ban over "propaganda activities" against the country, his lawyer told AFP on Monday.
Pope urges Lebanon's religious leaders to fight intolerance
Pope Leo XIV and leaders from Lebanon's religious communities met in a show of unity on Monday, with the pontiff urging them to combat intolerance on day two of his visit.
Hong Kong arrests suspects as fire death toll tops 150
Hong Kong has arrested 14 suspects in a probe into the city's deadliest fire in decades, finding "substandard" netting on building exteriors that failed to halt flames from spreading, authorities said Monday.
Pope prays for peace in Lebanon and the region
Pope Leo XIV prayed for peace in Lebanon and the region on Monday on day two of his trip to the multi-confessional country, with joyful Lebanese welcoming the pontiff at two famous pilgrimage sites.
Asia floods death toll tops 1,100 as troops aid survivors
The toll in deadly flooding and landslides across parts of Asia climbed past 1,100 on Monday as hardest-hit Sri Lanka and Indonesia deployed military personnel to help survivors.
Pope prays for peace in Lebanon, region
Pope Leo XIV prayed for peace in Lebanon and the region on Monday as he kicked off day two of his trip to the multi-confessional country with a visit to a famous pilgrimage site.
Asia floods toll tops 1,000 as military aid survivors
The toll in deadly flooding and landslides across parts of Asia climbed past 1,000 on Monday as hardest-hit Sri Lanka and Indonesia deployed military personnel to help survivors.
South Korean religious leader on trial on graft charges
The leader of one of South Korea's largest cult-like churches stood trial on Monday accused of bribing the country's former first lady with gifts including a designer handbag and a diamond necklace.
Militaries come to aid of Asia flood victims as toll nears 1,000
Sri Lanka and Indonesia deployed military personnel on Monday to help victims of devastating flooding that has killed nearly 1,000 people across four countries in Asia in recent days.
Migrant domestic workers seek support, solace after Hong Kong fire
Sobs could be heard across Hong Kong's Victoria Park at the weekend as hundreds of migrant workers mourned victims of Hong Kong's worst fire in more than a century and prayed for missing friends.
Pope to urge unity, bring hope to Lebanese youth on day two of visit
Pope Leo XIV is set to urge peace and unity on his second day in Lebanon on Monday, bringing a message of hope to young people whose faith in their crisis-hit country has dwindled.
Food Culture Subsidiary Distill Brands International Announces Selection of Distillery Partners for 2026 Product Lines
Three Accredited Distillery Partners to Serve as DBI Co-packers
Vastian to Showcase Connected Quality in Action at 2025 IHI Forum
LAWRENCEVILLE, GA / ACCESS Newswire / December 1, 2025 / Vastian, a leading provider of Quality management software for hospitals and laboratories, will showcase its innovative solutions at the 2025 IHI Forum, taking place December 7-10 in Anaheim, California. Visit Vastian at booth #605 to experience how its unified platform transforms Quality management from a regulatory requirement into a strategic driver of clinical excellence, patient safety, and operational efficiency.
Medical Care Technologies Inc. Moves Into Apple's Final TestFlight Testing Phase for Its Debut Consumer AI App
"MDCE Aims at a $13.4 Billion Worldwide Health & Nutrition App Market With Its First AI Consumer Platform."
1933 Industries Announces Year End 2025 Financial Results and Reports Positive Income
VANCOUVER, BC / ACCESS Newswire / December 1, 2025 / 1933 Industries Inc. (the "Company" or "1933 Industries")(CSE:TGIF)(OTCID:TGIFF), a Nevada-focused cannabis cultivator and producer, is pleased to announce its audited annual financial results for the years ended July 31, 2025 and 2024 ("Fiscal 2025"). All amounts expressed are in Canadian dollars.
Revelation Biosciences Has Reached A Quorum For Its December 3, 2025 Special Meeting
SAN DIEGO, CALIFORNIA / ACCESS Newswire / December 1, 2025 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company focused on rebalancing inflammation, today announced it has successfully reached a quorum for its Special Meeting scheduled for December 3, 2025. As a reminder, if you have not yet voted you have until 11:59pm ET tomorrow, December 2, 2025, to vote.
NanoViricides Has Signed a Master Services Agreement with OnlyOrphansCote Regarding Orphan Drug Strategy of NV-387 for Treatment of MPox, Smallpox, and Measles
SHELTON, CONNECTICUT / ACCESS Newswire / December 1, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine technology that viruses cannot escape, announced today that it has signed a Master Services Agreement (MSA) with Only Orphans Cote, LLC, ("OOC") a regulatory consultant firm founded by Dr. Timothy Cote. Dr. Cote and OOC will help the Company formulate its orphan drug strategy for NV-387, as well as develop relevant orphan drug designation applications and prosecute these applications at the US FDA Office of Orphan Products.